Tag:
Singapore
Latest Headlines
Latest Headlines
Merck bulks up in China while cutting plants elsewhere
Merck has been cutting manufacturing operations around the globe in the face of challenged earnings but continues to expand in China 20 years after erecting its first manufacturing facility there.
GlaxoSmithKline inks 5-year R&D pact with A*STAR
The two groups have been working together for the past decade, helping build the city-state's reputation for R&D.
Singapore crew tests Dx for new intestinal lymphoma
Researchers in Singapore and colleagues across Asia made two major advances in lymphoma diagnostics that offers both bad and good news.
Pfizer's Singapore slash and burn could be good news for CROs
Pfizer is dumping its clinical research operation in Singapore, part of an effort to cut about $1.3 billion from its R&D budget, and the divestiture could mean more opportunity for outsourcers looking to partner with the drug giant.
Pfizer cuts some more, closing R&D site in Singapore
As Pfizer continues to cut costs, it has just taken the ax to a clinical research facility in a market where others are beefing up, Singapore.
Pfizer to lop off Asian research unit amid major R&D downsizing
As the drug giant seeks to carve out more than $1 billion for its budget, Pfizer confirmed plans to exit a clinical research operation in Singapore.
Amgen likes Singapore for expansion
Amgen, which has been riding a wave of investor goodwill, is looking to produce products in Asia to be closer to that rapidly growing market.
Amgen to build $200 million Singapore plant
Biotech Amgen will build its first manufacturing plant in Asia, having landed on Singapore as a good location to expand globally.
GoBalto rakes in $12M for cloud-based clinical development
San Francisco's goBalto has pulled in $12 million in Series B financing to advance its cloud-based clinical development platform, which allows sponsors and CROs to monitor and collaborate on study results.
AMRI shutters R&D site, moving jobs to Singapore
The Bothell plant employs 24 people, AMRI said in a statement, and the cost-cutting measure is designed to "address and anticipate changes in the marketplace," according to the company.
